Work

Real-world outcomes with immuno-oncology (IO) therapies: A prospective, observational cohort study in patients (pts) with advanced melanoma (OPTIMIzE).

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.e14144

Authors: John M. Kirkwood, Lisa A. Kottschade, Robert R. McWilliams, Nikhil I. Khushalani, Sekwon Jang, Sigrun Hallmeyer, David F. McDermott, Hussein Abdul-Hassan Tawbi, Yin Wan, Rosa Wang, Corey Ritchings, Sumati Rao, Scott Ramsey

Institutions: University of Pittsburgh, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Mayo Clinic, Moffitt Cancer Center, Virginia Commonwealth University, Beth Israel Deaconess Medical Center, The University of Texas MD Anderson Cancer Center, Bristol-Myers Squibb (United States), Fred Hutch Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947789954

Cites:

Cited by: 1

Related to: 10